Axonal damage and loss of connectivity in nigrostriatal and mesolimbic dopamine pathways in early Parkinson's disease

被引:96
|
作者
Caminiti, Silvia Paola [1 ,2 ]
Presotto, Luca [2 ]
Baroncini, Damiano [3 ]
Garibotto, Valentina [4 ]
Moresco, Rosa Maria [5 ,6 ]
Gianolli, Luigi [7 ]
Volonte, Maria Antonietta [3 ]
Antonini, Angelo [8 ,9 ]
Perani, Daniela [1 ,2 ,7 ]
机构
[1] Univ Vita Salute San Raffaele, Via Olgettina 58, I-20132 Milan, Italy
[2] Ist Sci San Raffaele, Div Neurosci, Via Olgettina 58, I-20132 Milan, Italy
[3] Osped San Raffaele, Dept Neurol, Via Olgettina 60, I-20132 Milan, Italy
[4] Univ Geneva, Geneva Univ Hosp, Dept Med Imaging, Geneva, Switzerland
[5] IBFM CNR, Segrate, Italy
[6] Univ Milano Bicocca, Dept Hlth Sci, Tecnomed Fdn, Monza, Italy
[7] Osped San Raffaele, Nucl Med Unit, Via Olgettina 60, I-20132 Milan, Italy
[8] IRCCS Hosp San Camillo, Parkinsons Dis & Movement Disorders Unit, Via Alberoni 70, I-30126 Venice, Italy
[9] Univ Padua, Dept Neurosci DNS, Via Giustiniani 5, I-35128 Padua, Italy
关键词
Parkinson's disease; Positron emission tomography; Dopamine transporter; Axonal damage; Molecular connectivity; VENTRAL TEGMENTAL AREA; POSITRON-EMISSION-TOMOGRAPHY; FUNCTIONAL CONNECTIVITY; SUBSTANTIA-NIGRA; BRAIN; TRANSPORTER; PET; DISORDERS; PATHOLOGY; NETWORKS;
D O I
10.1016/j.nicl.2017.03.011
中图分类号
R445 [影像诊断学];
学科分类号
100207 ;
摘要
A progressive loss of dopamine neurons in the substantia nigra (SN) is considered the main feature of idiopathic Parkinson's disease (PD). Recent neuropathological evidence however suggests that the axons of the nigrostriatal dopaminergic system are the earliest target of a-synuclein accumulation in PD, thus the principal site for vulnerability. Whether this applies to in vivo PD, and also to the mesolimbic system has not been investigated yet. We used [C-11]FeCIT PET to measure presynaptic dopamine transporter (DAT) activity in both nigrostriatal and mesolimbic systems, in 36 early PD patients (mean disease duration in months +/- SD 21.8 +/- 10.7) and 14 healthy controls similar for age. We also performed anatomically-driven partial correlation analysis to evaluate possible changes in the connectivity within both the dopamine networks at an early clinical phase. In the nigrostriatal system, we found a severe DAT reduction in the afferents to the dorsal putamen (DPU) (eta(2) = 0.84), whereas the SN was the less affected region (eta(2) = 0.31). DAT activity in the ventral tegmental area (VTA) and the ventral striatum (VST) were also reduced in the patient group, but to a lesser degree (VST eta(2) = 0.71 and VTA eta(2) = 0.31). In the PD patients compared to the controls, there was a marked decrease in dopamine network connectivity between SN and DPU nodes, supporting the significant derangement in the nigrostriatal pathway. These results suggest that neurodegeneration in the dopamine pathways is initially more prominent in the afferent axons and more severe in the nigrostriatal system. Considering PD as a disconnection syndrome starting from the axons, it would justify neuroprotective interventions even if patients have already manifested clinical symptoms.
引用
收藏
页码:734 / 740
页数:7
相关论文
共 50 条
  • [31] Longitudinal functional connectivity changes related to dopaminergic decline in Parkinson's disease
    Li, Weihua
    Lao-Kaim, Nick P.
    Roussakis, Andreas-Antonios
    Martin-Bastida, Antonio
    Valle-Guzman, Natalie
    Paul, Gesine
    Soreq, Eyal
    Daws, Richard E.
    Foltynie, Tom
    Barker, Roger A.
    Hampshire, Adam
    Piccini, Paola
    NEUROIMAGE-CLINICAL, 2020, 28
  • [32] Association of daytime sleepiness with nigrostriatal dopaminergic degeneration in early Parkinson's disease
    Happe, Svenja
    Baier, Paul Christian
    Helmschmied, Kathrin
    Meller, Johannes
    Tatsch, Klaus
    Paulus, Walter
    JOURNAL OF NEUROLOGY, 2007, 254 (08) : 1037 - 1043
  • [33] Estrogen is essential for maintaining nigrostriatal dopamine neurons in primates: Implications for Parkinson's disease and memory
    Leranth, C
    Roth, RH
    Elswoth, JD
    Naftolin, F
    Horvath, TL
    Redmond, DE
    JOURNAL OF NEUROSCIENCE, 2000, 20 (23) : 8604 - 8609
  • [34] Association of daytime sleepiness with nigrostriatal dopaminergic degeneration in early Parkinson's disease
    Svenja Happe
    Paul Christian Baier
    Kathrin Helmschmied
    Johannes Meller
    Klaus Tatsch
    Walter Paulus
    Journal of Neurology, 2007, 254 : 1037 - 1043
  • [35] Basic research on dopamine in Parkinson's disease and the discovery of the nigrostriatal dopamine pathway: The view of an eyewitness
    Hornykiewicz, Oleh
    NEURODEGENERATIVE DISEASES, 2008, 5 (3-4) : 114 - 117
  • [36] Degeneration of nigrostriatal dopaminergic neurons in the early to intermediate stage of dementia with Lewy bodies and Parkinson's disease
    Okitsu, Masato
    Sugaya, Keizo
    Nakata, Yasuhiro
    Kawazoe, Tomoya
    Ikezawa, Jun
    Okiyama, Ryoichi
    Takahashi, Kazushi
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 449
  • [37] Association of body mass index and the depletion of nigrostriatal dopamine in Parkinson's disease
    Lee, Jae Jung
    Oh, Jungsu S.
    Ham, Jee H.
    Lee, Dong H.
    Lee, Injoo
    Sohn, Young H.
    Kim, Jae S.
    Lee, Phil Hyu
    NEUROBIOLOGY OF AGING, 2016, 38 : 197 - 204
  • [38] Tetrabenazine Mitigates Aberrant Release and Clearance of Dopamine in the Nigrostriatal System, and Alleviates L-DOPA-Induced Dyskinesia in a Mouse Model of Parkinson's Disease
    Tseng, Kuan-Yin
    Kuo, Tung-Tai
    Wang, Vicki
    Huang, Eagle Yi-Kung
    Ma, Kuo-Hsing
    Olson, Lars
    Hoffer, Barry J.
    Chen, Yuan-Hao
    JOURNAL OF PARKINSONS DISEASE, 2022, 12 (05) : 1545 - 1565
  • [39] Dopaminergic pathways and resting-state functional connectivity in Parkinson's disease with freezing of gait
    Steidel, Kenan
    Ruppert, Marina C.
    Palaghia, Irina
    Greuel, Andrea
    Tahmasian, Masoud
    Maier, Franziska
    Hammes, Jochen
    van Eimeren, Thilo
    Timmermann, Lars
    Tittgemeyer, Marc
    Drzezga, Alexander
    Pedrosa, David
    Eggers, Carsten
    NEUROIMAGE-CLINICAL, 2021, 32
  • [40] Interaction of caudate dopamine depletion and brain metabolic changes with cognitive dysfunction in early Parkinson's disease
    Polito, Cristina
    Berti, Valentina
    Ramat, Silvia
    Vanzi, Eleonora
    De Cristofaro, Maria Teresa
    Pellicano, Giannantonio
    Mungai, Francesco
    Marini, Paolo
    Formiconi, Andreas Robert
    Sorbi, Sandro
    Pupi, Alberto
    NEUROBIOLOGY OF AGING, 2012, 33 (01) : 206.e29 - 206.e39